|
注册号: Registration number: |
ChiCTR2400079663 |
|
最近更新日期: Date of Last Refreshed on: |
2024-09-19 17:55:27 |
|
注册时间: Date of Registration: |
2024-01-09 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
对比丙泊酚和瑞马唑仑对于小儿大脑网络联接功能的影响:一项随机对照研究 |
|
Public title: |
Comparison of the effects of propofol and remazolam on brain network functional connectivity in children: a randomized controlled trial |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
对比丙泊酚和瑞马唑仑对于小儿大脑网络联接功能的影响:一项随机对照研究 |
|
Scientific title: |
Comparison of the effects of propofol and remazolam on brain network functional connectivity in children: a randomized controlled trial |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
孔昊 |
研究负责人: |
孔昊 |
|
Applicant: |
Kong Hao |
Study leader: |
Kong Hao |
|
申请注册联系人电话: Applicant telephone: |
+86 186 1104 1430 |
研究负责人电话:
Study leader's |
+86 186 1104 1430 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
konghao2438@126.com |
研究负责人电子邮件: Study leader's E-mail: |
konghao2438@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
宁夏回族自治区银川市金凤区湖畔路127号 |
研究负责人通讯地址: |
宁夏回族自治区银川市金凤区湖畔路127号 |
|
Applicant address: |
127 Hupan Road, Jinfeng District, Yinchuan, Ningxia Hui Autonomous Region |
Study leader's address: |
127 Hupan Road, Jinfeng District, Yinchuan, Ningxia Hui Autonomous Region |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
北京大学第一医院宁夏妇女儿童医院 |
||
|
Applicant's institution: |
Peking University First Hospital Ningxia Women's and Children's Hospital |
||
|
研究负责人所在单位: |
北京大学第一医院宁夏妇女儿童医院 |
||
|
Affiliation of the Leader: |
Peking University First Hospital Ningxia Women's and Children's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KJ-LL-2023-72 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
北京大学第一医院宁夏妇女儿童医院(宁夏回族自治区妇幼保健院)伦理委员会 |
||
|
Name of the ethic committee: |
Ethics Committee of Peking University First Hospital Ningxia Women's and Children's Hospital (Ningxia Hui Autonomous Region Maternal and Child Health Hospital) |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2023-11-30 00:00:00 | ||
|
伦理委员会联系人: |
张米玮 |
||
|
Contact Name of the ethic committee: |
Zhang Mi-Wei |
||
|
伦理委员会联系地址: |
宁夏回族自治区银川市金凤区湖畔路127号 |
||
|
Contact Address of the ethic committee: |
127 Hupan Road, Jinfeng District, Yinchuan, Ningxia Hui Autonomous Region |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 157 1959 7322 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
北京大学第一医院宁夏妇女儿童医院(宁夏回族自治区妇幼保健院) |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor: |
Peking University First Hospital Ningxia Women's and Children's Hospital (Ningxia Hui Autonomous Region Maternal and Child Health Hospital) |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
宁夏回族自治区银川市金凤区湖畔路127号 |
||||||||||||||||||||||||||||||||||||||||||||
|
Primary sponsor's address: |
127 Hupan Road, Jinfeng District, Yinchuan, Ningxia Hui Autonomous Region |
||||||||||||||||||||||||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
经费或物资来源: |
无 |
||||||||||||||||||||||||||||||||||||||||||||
|
Source(s) of funding: |
None |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease: |
None |
||||||||||||||||||||||||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||||||||||||||||||||||||
|
研究目的: |
通过功能性近红外光谱技术,对比瑞马唑仑和丙泊酚对于小儿大脑皮层网络联接功能的影响 |
||||||||||||||||||||||||||||||||||||||||||||
|
Objectives of Study: |
Compare the effects of remazolam and propofol on cortical network functional connectivity in children by functional near-infrared spectroscopy (fNIRS) monitoring |
||||||||||||||||||||||||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||||||||||||||||||||||||
|
排除标准: |
凡具有下列情况之一者,不作为入选病例: (1)小儿或其法定监护人拒绝参加本研究; (2)拟行心脏手术或神经外科手术; (3)神经系统发育不良或合并神经系统疾病; (4)视力或听力障碍无法完成谵妄评估; (5)深度镇静(Richmond Agitation Sedation Score为-4或-5)或昏迷。 |
||||||||||||||||||||||||||||||||||||||||||||
|
Exclusion criteria: |
Those who meet one of the following criteria shall not be considered as selected cases: (1) Children or their legal guardians refuse to participate in this study; (2) Patients undergo cardiac or neurological surgery; (3) Patients with neurodevelopmental disorders or other neurological disorders. (4) Unable to complete delirium assessment due to visual or hearing impairment; (5) Deep sedation (Richmond Agitation Sedation Score -4 or -5) or in coma. |
||||||||||||||||||||||||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-05-01 00:00:00至 To 2025-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2024-05-01 00:00:00 至 To 2025-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
采用区组随机(区组大小4),由独立的生物统计学家使用SAS统计软件,按试验组和对照组1:1的比例随机产生随机数字。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Using block randomization (block size of 4), biostatisticians used SAS statistical software to generate random numbers according to the ratio of 1:1 between the intervention group and the control group. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
1.对随机编码施盲。 2.对研究人员施盲:负责术前筛选患者和术后随访的研究人员不参加患者的麻醉管理,亦不知道患者的分组情况;研究人员和麻醉管理人员不能交流术中麻醉管理情况。 3.对患者施盲:患者在整个围术期对自己的分组情况不知情。 4.对fNIRS信息的分析人员施盲。 |
|
Blinding: |
1.Blind random coding. 2.Blinding the researchers: the researchers who are responsible for preoperative screening of patients and postoperative follow-up do not participate in the anesthesia management of patients, and do not know the grouping of patients; the researchers and anesthesia managers can not communicate the anesthesia management during the operation. 3.Blinding the patients: the patients were not aware of their grouping during the whole perioperative period. 4. Blinding the analysts of fNIRS data. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
临床试验完成后1年内联系研究者konghao2438@126.com获取。 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Contact the researcher (konghao2438@126.com) within one year after the completion of the clinical trial. |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例报告表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case record form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |